Osteopore Limited, a Singapore-based medical device company, has patients in more than25 countries.They have regulatory access and operation in more than20 countriesand autonomous regions, including theUS, Europe, Asia, and Australia.
They have also expanded into theAfricanmarket with initial sales inSouth Africa.Other specific countries mentioned includeColombia, Spain, New Zealand, and they have also achieved sales in the aesthetic market inSouth Korea, Singapore, Thailand, Vietnam, and the Philippines
Ann: First-in-human clinical trials begin in Singapore, page-34
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
